TCL Archive Seer Places Survival Now at Least At 45 Percent, Could Be As High As 50 Percent For 1973-79 Patients December 4, 1981
TCL Archive DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program November 1, 1985
TCL Archive Cancer clinical trials cooperative groups are in jeopardy, and changes are needed to enable the system to survive, chairmen of the groups wrote in a paper submitted to NCI. White paper makes 25 recommendations, including changing system incentives, review process, group integration with centers and SPOREs, and inclusion in CaBIG. This 8-page issue includes full text of the white paper. April 2, 2004
